1. Health
Send to a Friend via Email

Discuss in my forum

Nancy Schimelpfening

Generic Lexapro Receives FDA Approval

By March 29, 2012

Follow me on:

On March 14, 2012, the U.S. Food and Drug Administration approved the first generic version of the antidepressant Lexapro (escitalopram).

The generic version of the drug will be manufactured by Teva Pharmaceutical Industries/VAX Pharmaceuticals, an American company which produces many generic medications, and they will be the sole provider of the generic form of the drug for six months.

Teva will provide the drug in 5-, 10- and 20-mg doses, and, like the brand-name version, it is approved for the treatment of adult depression and generalized anxiety disorder.

Escitalopram belongs to a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs), whose mode of action involves blocking the reuptake of serotonin by brain cells causing more of this important mood regulator to be available for use.

Common side effects of SSRIs include insomnia, ejaculation disorder, nausea, increased sweating, fatigue, sleepiness and decreased sex drive.

As with other antidepressants, escitalopram may cause increased risk of suicidal thoughts and behaviors in children, teens and young adults under the age of 25 when treatment is first begun.

Related Articles:

Comments
April 7, 2012 at 5:42 pm
(1) J L says:

This is great, Lexapro is the only thing that has proven results in my life, I lost my job and insurance so I could not afford 140$ for a month supply. I am so glad this happened,

Leave a Comment

Line and paragraph breaks are automatic. Some HTML allowed: <a href="" title="">, <b>, <i>, <strike>
  1. About.com
  2. Health
  3. Depression

©2014 About.com. All rights reserved.

We comply with the HONcode standard
for trustworthy health
information: verify here.